| European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for … I Meattini, C Becherini, L Boersma, O Kaidar-Person, GN Marta, ... The Lancet Oncology 23 (1), e21-e31, 2022 | 177 | 2022 |
| Hypofractionated radiation therapy for breast cancer: Preferences amongst radiation oncologists in Europe–Results from an international survey I Ratosa, ME Chirilă, M Steinacher, E Kozma, R Vojtíšek, P Franco, ... Radiotherapy and Oncology 155, 17-26, 2021 | 39 | 2021 |
| Breast size impact on adjuvant radiotherapy adverse effects and dose parameters in treatment planning I Ratosa, A Jenko, I Oblak Radiology and oncology 52 (3), 233-244, 2018 | 38 | 2018 |
| Cardiotoxicity of mediastinal radiotherapy I Ratosa, MI Pantar Reports of Practical Oncology and Radiotherapy 24 (6), 629-643, 2019 | 37 | 2019 |
| Telemedicine in radiation oncology post–COVID-19 pandemic: there is no turning Back M Orazem, I Oblak, T Spanic, I Ratosa International Journal of Radiation Oncology* Biology* Physics 108 (2), 411-415, 2020 | 30 | 2020 |
| Cyclin-dependent kinase 4/6 inhibitors combined with radiotherapy for patients with metastatic breast cancer I Ratosa, M Orazem, E Scoccimarro, M Steinacher, L Dominici, ... Clinical Breast Cancer 20 (6), 495-502, 2020 | 27 | 2020 |
| Breast cancer patients with brain metastases or leptomeningeal disease: 10‐year results of a national cohort with validation of prognostic indexes T Znidaric, J Gugic, T Marinko, A Gojkovic Horvat, MS Paulin Kosir, ... The Breast Journal 25 (6), 1117-1125, 2019 | 26 | 2019 |
| General overview and treatment recommendations for young women with breast cancer D Ribnikar, I Ratoša, A Perhavec, E Amir Revista de investigación clínica 69 (2), 77-93, 2017 | 22 | 2017 |
| Long-term use of metformin and the molecular subtype in invasive breast carcinoma patients–a retrospective study of clinical and tumor characteristics N Besic, N Satej, I Ratosa, AG Horvat, T Marinko, B Gazic, R Petric BMC cancer 14, 1-7, 2014 | 19 | 2014 |
| Improved survival after breast-conserving therapy compared with mastectomy in stage I-IIA breast cancer I Ratosa, G Plavc, N Pislar, T Zagar, A Perhavec, P Franco Cancers 13 (16), 4044, 2021 | 14 | 2021 |
| Explaining variation in quality of breast cancer care and its impact: a nationwide population-based study from Slovenia G Plavc, I Ratoša, T Žagar, V Zadnik Breast Cancer Research and Treatment 175, 585-594, 2019 | 12 | 2019 |
| Leptomeningeal metastases in patients with human epidermal growth factor receptor 2 positive breast cancer: Real‐world data from a multicentric European cohort I Ratosa, N Dobnikar, M Bottosso, MV Dieci, W Jacot, S Pouderoux, ... International Journal of Cancer 151 (8), 1355-1366, 2022 | 11 | 2022 |
| Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases AM Lazaratos, SM Maritan, A Quaiattini, A Darlix, I Ratosa, E Ferraro, ... The Breast 69, 451-468, 2023 | 9 | 2023 |
| Smernice diagnostike in zdravljenja raka dojk A Blatnik, A Perhavec, B Gazić, B Vidergar-Kralj, E Matos, I Ratoša, ... Onkološki inštitut, 2018 | 9 | 2018 |
| Breast size and dose to cardiac substructures in adjuvant three-dimensional conformal radiotherapy compared to tangential intensity modulated radiotherapy I Ratosa, A Jenko, Z Sljivic, M Pirnat, I Oblak Radiology and Oncology 54 (4), 470-479, 2020 | 8 | 2020 |
| Preoperative treatment with radiochemotherapy for locally advanced gastroesophageal junction cancer and unresectable locally advanced gastric cancer I Ratosa, I Oblak, F Anderluh, V Velenik, J But-Hadzic, AS Secerov, ... Radiology and oncology 49 (2), 163-172, 2015 | 8 | 2015 |
| Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer L Visani, L Livi, I Ratosa, M Orazem, D Ribnikar, C Saieva, C Becherini, ... Radiotherapy and Oncology 177, 40-45, 2022 | 6 | 2022 |
| Uvod, zgodovina in prihodnost stereotaktičnega obsevanja I Ratoša Stereotaktično obsevanje: novi izzivi zdravljenja v radioterapiji:[strokovno …, 2020 | 6 | 2020 |
| Oligometastatski rak I Ratoša, K Stanič, T Ovčariček, A Šečerov Ermenc, J Čarman, B Grošelj, ... Onkologija. strokovni časopis za zdravnike 26 (2), 22-28, 2022 | 5 | 2022 |
| COVID-19 pandemic as an opportunity for the radiotherapy department M Orazem, I Ratosa Clinical Oncology 32 (8), e175-e176, 2020 | 5 | 2020 |
